Cartesian Growth Corp II 

$12.71
0
+$0.6+4.95% Friday 13:30

Statistics

Day High
12.71
Day Low
12.71
52W High
12.71
52W Low
11.05
Volume
2
Avg. Volume
-
Mkt Cap
112.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Profitable
2021
2022
2023
2024
0Revenue
16.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RENEF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.
Show more...
CEO
Dr. Peter Michael Yu Ph.D.
Country
United States
ISIN
KYG193051128

Listings

0 Comments

Share your thoughts

FAQ

What is Cartesian Growth Corp II stock price today?
The current price of RENEF is $12.71 USD — it has increased by +4.95% in the past 24 hours. Watch Cartesian Growth Corp II stock price performance more closely on the chart.
What is Cartesian Growth Corp II stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cartesian Growth Corp II stocks are traded under the ticker RENEF.
What is Cartesian Growth Corp II market cap?
Today Cartesian Growth Corp II has the market capitalization of 112.18M
What is Cartesian Growth Corp II revenue for the last year?
Cartesian Growth Corp II revenue for the last year amounts to 0 USD.
What is Cartesian Growth Corp II net income for the last year?
RENEF net income for the last year is 16.41M USD.
In which sector is Cartesian Growth Corp II located?
Cartesian Growth Corp II operates in the Other sector.
When did Cartesian Growth Corp II complete a stock split?
Cartesian Growth Corp II has not had any recent stock splits.
Where is Cartesian Growth Corp II headquartered?
Cartesian Growth Corp II is headquartered in New York, United States.